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KEY POINTS
 Cognitive stimulation therapy is a psychological treatment for people with mild and mod-
erate dementia.
 It is offered in both a group and individual format showing various benefits on cognitive
functioning, quality of life, and quality of the caregiving relationship.
 The intervention provides a fun and meaningful approach toward staying mentally stimu-
lated and engaged.
 The World Alzheimer’s Report 2014 recommends cognitive stimulation therapy to be
offered routinely to people with dementia around the world.
 In the future, cognitive stimulation therapy based approaches will hopefully grow and be
made available to people who want and need it the most.INTRODUCTION
Cognitive stimulation therapy (CST) is a brief psychological treatment for people with
mild to moderate dementia. It offers a person-based approach to help people with de-
mentia to stay mentally stimulated and engaged while providing an optimal learning
environment. Over the course of 20 years, CST has grown to be widely used with 3
CST manuals published to date. Currently, CST is the only nonpharmacologic therapyDisclosure Statement: Royalties from the sale of the Making a Difference manuals go to the
support of the international CST center at UCL run by Dr Aimee Spector. H. Rai is working
with Eumedianet on the development of a web app version of CST as part of her PhD.
a Division of Psychiatry and Applied Psychology, Institute of Mental Health, School of Medicine,
University of Nottingham, Jubilee Campus, Triumph Road, Nottingham NG7 2TU, UK; b Division
of Psychiatry and Applied Psychology, Institute of Mental Health, School of Medicine, Uni-
versity of Nottingham, Jubilee Campus, University of Nottingham Innovation Park, Triumph
Road, Nottingham NG7 2TU, UK; c Division of Psychiatry and Applied Psychology, Faculty of
Medicine and Health Sciences, Institute of Mental Health, University of Nottingham, Jubilee
Campus, University of Nottingham Innovation Park, Triumph Road, Nottingham NG7 2TU, UK Q5
* Corresponding author.
E-mail address: Harleen.Rai@nottingham.ac.uk
CGM903_proof ■ 24 July 2018 ■ 11:39 pm
Clin Geriatr Med - (2018) -–-
https://doi.org/10.1016/j.cger.2018.06.010 geriatric.theclinics.com
0749-0690/18/ª 2018 Elsevier Inc. All rights reserved.
Rai et al2
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99recommended by the National Institute for Health & Clinical Excellence guidelines
(2006) for treating cognitive symptoms of dementia in the UK. These guidelines advise
that CST should be available to people with dementia regardless of medication
received. In addition, nearly all memory services in the UK currently offer CST in reg-
ular groups with people with dementia.1 On a global level, CST is now recommended
to be offered routinely to people with dementia around the world in the World
Alzheimer’s Report produced by Alzheimer Disease International in 2011. The Interna-
tional CST Center at University College London (UCL) has supported the adaptation
and/or implementation of CST in more than 25 countries. Furthermore, the first 2 inter-
national CST conferences brought together researchers, clinicians, and other stake-
holders from around the world to discuss past work and to exchange new and
exciting ideas regarding CST. In Hong Kong, delegates learned about the concept
of a virtual feature for CST groups where people would be able to attend CST groups
from the comfort of their homes, connecting with others via a video/audio channel on a
technological device. CST shows measurable benefits on cognition and quality of life
(QoL) comparable with the effects of some antidementia mediation. In addition, it is
cost effective2 and very much enjoyed by people with dementia. All of these factors
have undoubtedly supported the national and international uptake of the intervention.
The field of CST remains ever evolving and further to what has been achieved so far,
there is much to look forward to in terms of innovations.BACKGROUND
CST was developed 20 years ago at a time when there were few psychological ther-
apies available for people with dementia and the potential for engagement in mentally
stimulating, enjoyable activities in everyday life to preserve cognitive health and pro-
tect against decline had not been realized. From the perspective of the population,
there was a clear need to have something available that would provide people with de-
mentia with a meaningful way to spend their time. Clinicians and policymakers antic-
ipated the development of new antidementia medication because the benefits of
tacrine, the only pharmacologic therapy available, were modest and the risks of
adverse events made the drug unsuitable for some people with dementia. Therefore,
the field of psychological treatments remained unexplored and trials for psychological
interventions were often small in scale and methodologically unsound. From a
research perspective, the need for more rigorous investigation of new and/or existing
psychological therapies for people with dementia was evident. Considering both the
gaps in research and the needs of people with dementia, a research team in the UK
set out to develop a novel, psychological therapy whose evaluation would be built
on a strong methodological foundation comparable with that of pharmacologic
treatments.3
The first steps toward developing CST included the review of evidence from existing
psychological therapies which could serve as a strong foundation. This review
included 2 systematic literature reviews on reality orientation (RO) and reminiscence
therapy, 2 widely used psychological approaches. In addition, the work on CST was
influenced by Breuil’s approach to cognitive stimulation.4 Whereas RO is described
as the presentation and repetition of orientation-based information, Breuil’s approach
differed from traditional RO by setting out to engage people in enjoyable cognitive
tasks provided in a group format. Breuil and colleagues (1994)4 conducted a random-
ized, controlled trial among 56 people with dementia and found their cognitive stimu-
lation approach had positive effects on cognitive functioning. The workgroup went on
to combine the effective techniques from key therapies (RO, reminiscence therapyCGM903_proof ■ 24 July 2018 ■ 11:39 pm
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150and, Breuil and colleagues’s work) and multisensory stimulation to form the CST
program.
CST consists of 14 twice-weekly group sessions (Table 1) that take place over the
course of 7 weeks.5 All sessions are diverse in nature and the program offers a wide
array of topics to ensure it meets the group’s interests and cognitive abilities. Every
CST group has personalized elements to it, such as choice of a group name and
song. These are displayed on an RO board during the session. Sessions last 45 mi-
nutes including a 10-minute noncognitive warmup and a 10-minute closing activity
(summary and/or the group song). CST is typically delivered by a trained health
care professional or care assistant to groups of 5 to 8 people. The facilitators are
encouraged to adhere to the key principles of CST, which helps to create the most
optimal environment for mental stimulation and enjoyment. Examples of the 18 key
principles are mental stimulation, using reminiscence as an aid to the here and now,
implicit learning, fun, choice, building/strengthening relationships, and focusing on
opinions, rather than facts. These features are unique to CST.
EVIDENCE
The development of CST followed the guidance of the Medical Research Council
framework for developing complex interventions.6 This framework includes a develop-
ment–evaluation–implementation process in which all the phases interact with each
other.
The first draft version of CST was taken forward in a pilot study.7 A total of 27 people
with dementia, recruited from a day center and 3 residential homes, were included.
Seventeen were randomized to the treatment group receiving CST and 10 were allo-
cated to a treatment as usual control group. The results were promising and indicated
that for the CST treatment group there were positive signs regarding cognition, and
depression and anxiety seemed to be reduced compared with the control group.Table 1
Cognitive stimulation therapy sessions
Session Content
1 Physical games
2 Sound
3 Childhood
4 Food
5 Current affairs
6 Faces/scenes
7 Associated words
8 Being creative
9 Categorizing objects
10 Orientation
11 Using money
12 Number games
13 Word games
14 Team games
Data from Spector A. Introduction. In: Yates LA, Yates J, Orrell M, et al, editors. Cognitive stimula-
tion therapy for dementia: history, evolution and internationalism. 1st edition. Oxford (England):
Routledge; 2017. p. 177–93.
CGM903_proof ■ 24 July 2018 ■ 11:39 pm
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from this pilot study formed a strong argument for investigating the effects of CST in a
large randomized, controlled trial.
After a few adjustments to the CST program according to the findings from the pilot
study, a single-blind, multicenter randomized, controlled trial was conducted that
included 201 people with dementia.8 The participants were distributed over 23 CST
groups and were recruited from 5 day centers and 18 care homes. The following inclu-
sion criteria applied to all participants:
 Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria for
dementia9;
 Score of between 10 and 24 on the Mini Mental State Examination10;
 Some ability to communicate and understand (eg, ability to give informed
consent);
 Able to see and hear well enough to participate in the group and make use of
most of the material in the program; and
 No major physical illness, learning disability, or other disability that could affect
participation.
These inclusion criteria have been commonly applied in CST studies since, and are
now referred to as the Spector and colleagues (2003) standardized criteria.
Participants were randomized to either a CST group (n 5 115) or a treatment as
usual control group (n 5 86). Researchers aimed to assess benefits across several
outcomes measures with primary outcomes of cognitive functioning and QoL. The trial
results were positive: participants in the CST group showed significant improvements
in cognitive functioning as measured by the Mini Mental State Examination10 and the
Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog)11 compared
with the treatment as usual group. Self-rated QoL was higher in the CST group as
measured by the Quality of Life-AD.12 Last, there was a positive trend for communica-
tion (Holden Communication Scale).13 No significant differences were found for the
secondary outcomes such as functional ability, anxiety, and depression.
The trial met some challenges and the research team made key observations that
helped them to better understand the results.14 One of the limitations was the short
follow-up period, which consisted of 8 weeks and did not allow for any evidence
regarding long-term effects of CST. In addition, none of the staff-rated scales showed
any significant benefits (behavior, mood, communication). The researchers did
observe a considerable amount of variation between centers in terms of the effects
on the outcome measures. This finding could be due to the role of staff members
and the quality of the environment, but also to the level of impairment of participants.
At times, if people with dementia were functioning quite well already, there was little
room for significant improvement. It could also be difficult to run groups with people
with different stages of dementia because those with mild impairment sometimes
grew frustrated with participants with a greater degree of impairment. To maximize
the effectiveness of the intervention, it is crucial to create an optimal learning environ-
ment, including pitching the sessions to an appropriate level according the needs of
the group participants. Despite these challenges, the significant improvements on
the primary outcome measures and the fact that people with dementia really enjoyed
CST encouraged the research team to publish the CST training manual and to make it
more widely available.
A few years later, the CST findings from the trial were supported with qualitative data
when researchers investigated the experiences of people with dementia, carers, and
group facilitators who attended CST groups.15 This study included 38 participantsCGM903_proof ■ 24 July 2018 ■ 11:39 pm
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252recruited from 3 existing CST groups. Two main themes (along with 7 subthemes)
emerged from the focus groups and interviews: positive experiences of being in the
group and changes experienced in everyday life. Participants sharedmany reflections,
some of which are highlighted herein. Regarding changes in everyday life, participants
reported noticing some benefits in their memory:
Yes, remembering the recent events have been a lot more simple and a lot more
logical than it was certainly.
—Person with dementia
Cognitive benefits in other areas such as communication were also observed by
carers.
She’s clearer on the telephone. Clearer I suppose in the way she holds the con-
versation it’s not that she speaks differently. It’s just that the flow of the conversa-
tion is a little easier.
—Carer
Personal experiences reported by participants support the notion of CST being a
positive and mentally stimulating experience, which is in line with previous quantitative
findings.15Q7MAINTENANCE COGNITIVE STIMULATION THERAPY
The first CST trial showed positive results. However, the need for more research
regarding potential longer term outcomes and more CST content for people with
dementia in general, led to the development of an extended version of CST called
maintenance CST (MCST).16 The MCST program includes the regular 7-week CST
program with an extension of an additional 24 weekly maintenance sessions. Box 1
gives an overview of all the MCST themes in the published MCST manual.
Before finalizing the MCST program, an exploratory pilot study was conducted in 4
residential homes.17 After completion of the standard CST program, 2 residential
homes were offered 16 once weekly MCST sessions and the 2 remaining homes
served as treatment as usual control groups. Thirty-five participants were recruited
for the study which were allocated to 1 of the 3 groups: (1) MCST and CST (n 5 8),
(2) CST only (n 5 12), and (3) no CST (n 5 15). Results indicated a continuous, signif-
icant improvement at follow-up on cognitive functioning as measured by the Mini
Mental State Examination among participants receiving MCST (CST plus MCST)
compared with the CST only or the no CST groups. No significant effects were found
for QoL, communication, or behavior after MCST. It was evident that a fully developed
MCST program was needed to formally investigate the effects of CST delivered over a
longer term basis.17
The researchers considered the theory behind the original CST program and the
findings from the exploratory pilot study while finalizing the MCST program. In line
with CST, MCST was developed according to the Medical Research Council frame-
work and used a mixed methods approach.16 Evidence from the following sources
were combined: (1) a Cochrane review of cognitive stimulation for people with de-
mentia,18 (2) a Delphi consensus process (involving key stakeholders), (3) focus
groups with key stakeholders, and (4) a Delphi survey. This process led to the
development of the MCST manual, which includes themed sessions and resembles
the consistent structure of CST (eg, group name/song, noncognitive warmup).19
The finalized MCST program was evaluated in a large-scale randomized, controlled
trial.CGM903_proof ■ 24 July 2018 ■ 11:39 pm
Box 1
Maintenance cognitive stimulation therapy sessions themes
My life
Current affairs
Food
Being creative
Number game
Team games, quiz
Sound
Physical games
Categorizing objects
Household treasures (new)
Useful tips (new)
Thinking cards (new)
Visual clips (new)
Art discussion (new)
Faces/scenes
Word game
Associated words, discussion
Orientation
Using money
Data fromOrrell M, Forrester L. Group cognitive stimulation therapy: clinical trials. In: Yates LA,
Yates J, Orrell M, et al, editors. Cognitive stimulation therapy for dementia: history, evolution
and internationalism. 1st edition. Oxford (England): Routledge; 2017. Q12
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303The MCST trial was a single-blind, multicenter, pragmatic randomized, controlled
trial of the effects of MCST groups after the completion of the standard CST program
versus CST followed by treatment as usual.20 A total of 236 participants were recruited
from 9 care homes and 9 community services (eg, day centers). After completion of
the original CST program, participants were randomly allocated to either the additional
MCST program (n 5 123) or the treatment as usual control group (n 5 113). Partici-
pants were assessed at baseline before randomization had taken place, at 3 months,
and after 6 months. Similarly, with the previous CST trial, the primary outcomes mea-
sures were the ADAS-Cog11 and QoL-AD.12
Trial results indicated that, at the 6-month follow-up, the MCST treatment group
showed significant improvements in self-rated QoL-AD compared with the treatment
as usual control group.21 At the 3-month follow-up, results showed positive effects for
people with dementia on the proxy-rated QoL (Dementia Quality of Life question-
naire)22 by carers and care staff, and daily activities (Alzheimer’s Disease Cooperative
Study Activities of Daily Living Inventory).23 No significant effects were found on the
ADAS-Cog or other secondary outcomes at either follow-up.
The most notable difference between the findings from the MCST trial and the first
CST trial was the absence of improvements on cognition after MCST.21 Because de-
mentia is associated with a progressive decline in cognition, participants in both theCGM903_proof ■ 24 July 2018 ■ 11:39 pm
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354MCST and the control group were likely to have shown cognitive deterioration at the
6 month follow-up. This decline might have limited further cognitive improvement with
MCST after the standard CST program. Another key finding came from a substudy of
the MCST trial that investigated the use of acetylcholinesterase inhibitor medication in
combination with MCST. The substudy found that less cognitive decline occurred in
the MCST group taking acetylcholinesterase inhibitor medication compared with the
MCST group without medication and the treatment as usual group. This finding indi-
cates that better results might be obtained if pharmacologic treatments are combined
with CST. The research team concluded that more research is needed regarding
continued CST because this was the first rigorous trial of MCST and the results
did not seem to be conclusive. However, because the significant improvements on
QoL owing to MCST were an encouraging finding, the research team published the
MCST manual.INDIVIDUAL COGNITIVE STIMULATION THERAPY
With the increasing evidence for the benefits of CST and its uptake in routine ser-
vices, the need to offer CST through different avenues became apparent. It was
acknowledged that CST is not always accessible for those who are either unwilling
or unable to attend groups. Taking their needs and wishes in consideration, the in-
dividual version of CST (iCST) was developed. Unlike CST and MCST, iCST is home
based and is facilitated by an informal carer (eg, a family member, friend, or anyone
who is close to the person with dementia) or a paid carer (eg, home support
worker).
The development of iCST followed the Medical Research Council framework and
included several research activities.24 In the first stages of development, people
with dementia, carers, and care staff were asked to share their feedback and thoughts
on the idea of iCST in an informal survey. The research team then reviewed existing
literature of CST, MCST, one-to-one programs of cognitive stimulation, and RO.
The evidence collated from the literature was then reviewed by a small group of key
stakeholders such as carers and health care professionals who provided their advice
on important considerations for the adaptation of CST to iCST. These activities led to
the first draft of sessions 1 to 12 of the iCST manual, which were appraised in focus
groups and interviews with people with dementia and carers. Participants were gener-
ally positive about the iCST materials and also shared their views on mentally stimu-
lating activities and the feasibility of iCST. The research team proceeded with a field
testing phase of the full program, which included both informal carers and paid carers.
Both quantitative (eg, questionnaires, rating of enjoyment, interest, communication,
and level of interest) and qualitative data (eg, through telephone support) were
collected. Last, a 2-stage modified Delphi consensus process (online survey and con-
ference) was used to reach consensus on themes that participants of focus groups,
interviews, and field testing could not agree on. The sample consisted of academic,
health care professionals, researchers, and carers.24,25
The iCST intervention follows the same principles of group CST; however, a few ad-
justments had to be made to make it suitable for use at home. Instead of the introduc-
tion and closing element of group CST, iCST sessions begin with a discussion of
orientation information and current affairs followed by a themed activity. Each iCST
session lasts around 20 to 30 minutes and each CST and MCST session was split
to create 2 iCST sessions, which resulted in a 75-session program lasting over
25 weeks. Box 2 gives an overview of the iCST session themes; some themes occur
more than once. The iCST omits the key principles geared toward the group process;CGM903_proof ■ 24 July 2018 ■ 11:39 pm
Box 2
Individual cognitive stimulation therapy session themes
My life
Current affairs
Food
Being creative
Number games
Quiz games
Sounds
Physical games
Categorizing objects
Household treasures
Useful tips
Thinking cards
Visual clips discussion
Art discussion
Faces/scenes
Word games
Slogans (new)
Associated words discussion
Orientation
Using money
Childhood (new)
Data from Yates LA. Individual cognitive stimulation therapy (iCST). Group cognitive stimula-
tion therapy: clinical trials. In: Yates LA, Yates J, Orrell M, et al, editors. Cognitive stimulation
therapy for dementia: history, evolution and internationalism. 1st edition. Oxford (England):
Routledge; 2017. p. 69–88.
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405rather, it stimulates discussion between the person with dementia and the carer and
encourages them to enjoy the time they spend together.
The final iCST program was tested in a multicenter, single-blind, large-scale ran-
domized, controlled trial.26 A total of 356 participants were recruited from a variety
of community settings and allocated to either the iCST intervention group (n 5 180)
or the treatment as usual control group (n 5 176). All participants met the Spector
and colleagues (2003) standardized criteria with the addition of the following 2 criteria:
living in the community and the availability of an informal carer. The main outcome
measures were cognition (ADAS-Cog)11 and QoL for the person with dementia
(QoL-AD),12 and QoL of the carer (Short Form-12).27 The primary and secondary out-
comes measures were completed at 3 time points: baseline, first follow-up at
13 weeks, and second follow-up at 26 weeks. Throughout the trial, participants
received support from the research team in the form of regular telephone support
and monitoring visits. The trial results demonstrated no differences between the
iCST and treatment as usual control group on any of the primary outcome measures
at both follow-up time points. However, for one of the secondary outcome measures,CGM903_proof ■ 24 July 2018 ■ 11:39 pm
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456significant improvements in the quality of the caregiving relationship from the person
with dementia’s perspective were found. For the carers, scores on a secondary QoL
measure (EQ-5D)28 were significantly better in the iCST group at the second follow-
up.26
The results of this trial are not consistent with previous CST findings and the
following reflections may help us to better understand the iCST evidence. Because
the iCST is a longer intervention, the findings might indicate that a short-term, more
intense dose of CST could be more beneficial or effective. The social setting provided
during the group CST might also be crucial to enhancing cognition and QoL; thus,
lacking this feature, the iCST may not elicit benefits. It is suggested, in previous
research, that improvements in cognition from the CST mediate improvements in
QoL for people with dementia.18 Hence, the lack of change in cognition experienced
by iCST participants could explain the lack of results on QoL. The greatest challenge
of the trial proved to be adherence to iCST. The research team observed that, on
average, dyads completed just less than one-half of the recommended 75 sessions
over 25 weeks. Although, before the trial, during the development phase, carers deter-
mined the current iCST format to be feasible, in reality carers identified several barriers
to delivering the intervention after the trial, such as time constraints, physical health
problems, and motivation.
Despite the lack of significant effects on cognition and QoL, this trial was innovative
for several reasons. The iCST trial is the largest known piece of CST research to date
and it is the first trial investigating a home-based, carer-led format of CST. This trial
demonstrated that, in general, carers are able to deliver an intervention, which is a
key finding supporting carer-led interventions. The observed improvements in the
quality of the caregiving relationship are encouraging and could enhance the QoL of
people with dementia. The results from this trial are not conclusive and there is a
need for continued research on iCST to determine its exact effectiveness.INTERNATIONAL COGNITIVE STIMULATION THERAPY
CST was initially developed and implemented in the UK and, after its success, began
to attract international attention. Given the cultural differences in almost every country,
in addition to the language barriers, it was deemed crucial to have some kind of
framework in place that could facilitate the adaptation of CST. Therefore, the research
team at UCL set out to create guidelines that could inform the process of adapting
and translating the CST content and structure without compromising on its
effectiveness.29
The research team reviewed existing frameworks and theoretic methods that have
been developed to guide the cultural adaptation of existing interventions. Of the
frameworks reviewed, the formative method for adapting psychotherapy was chosen
to develop the CST guidelines owing to its community-based developmental
approach.30 This is a bottom-up approach in which people with dementia and other
service users are consulted as a preliminary step to uncover their ideas and opinions
(eg, how dementia is perceived in their culture). This step is essential because it pro-
vides an early understanding of how CST can be catered toward the needs of service
users in that specific country. The formative method for adapting psychotherapy
approach together with evidence from existing international CST groups resulted in
guidelines consisting of 5 phases, which are described in Fig. 1.
Currently, CST is used in all of the following developed and developing countries:
Australia, Brazil, Canada, Chile, China, Denmark, Germany, Greece, Hong Kong, In-
dia, Israel, Italy, Ireland, Indonesia, Japan, Nepal, the Netherlands, New Zealand,CGM903_proof ■ 24 July 2018 ■ 11:39 pm
Fig. 1. The 5 phases of cognitive stimulation therapy adaptation guidelines.
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507Nigeria, Philippines, Portugal, Singapore, South Africa, South Korea, Tanzania,
Turkey, and the United States.31 CST is especially relevant for developing countries
because it provides an effective low-cost intervention to help improve cognition and
QoL. Establishing the international CST center at UCL has been a crucial step toward
making CST more widely available because the center has been facilitating collabora-
tions and knowledge exchange between the more the 25 countries currently offering
CST.
COGNITIVE STIMULATION THERAPY IN THE UNITED STATES: A CASE STUDY
CST has been successfully adapted and implemented in the United States.32 The first
comprehensive CST programwas developed at the Perry County Memorial Hospital, a
small rural hospital in southeastern Missouri. Before its development, professionals
received visits and CST training from members of the UCL research team. CST was
found to be easily adaptable for the US population because the language barrier
was minimal and sessions that focused on universal topics such as faces and scenes
or food allowed for cultural adaptation.32 After the adaptation of group CST, re-
searchers compared pre-CST and post-CST data among both community-based
and residential-dwelling people with dementia (n 5 79) in which they found scores
for cognition and QoL to be higher after the CST. These findings have been encour-
aging and allowed for the expansion of CST at Perry County Memorial Hospital
from one, 6-member CST group to 10 CST groups currently running every week cater-
ing for 90 people with dementia. With regard to iCST, a family carer (daughter of a per-
son with dementia) evaluated it quite positively as illustrated by the following quote:
From discussion they had over architecture to deep thoughts on top news stories
to exploring timeless paintings to simply relishing in discussing the glorious days
of old, dad lover every moment. These weekly visits continued throughout dad’s
stay in the hospital and extended to his home post discharge. Dad would continue
on in thought and articulate communication. Their session bled over into the
everyday. And over time, dad became increasingly more fluent and lucid.CGM903_proof ■ 24 July 2018 ■ 11:39 pm
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558The US research team continues to provide CST training around the country and
plans to establish a US CST National Training Center are underway. The team hopes
to publish an adapted CST manual in the near future.
SUMMARY AND FUTURE DIRECTIONS
The CST journey has spanned for more than 20 years so far and innovations continue
to be made in this field. When CST was developed, it helped to fill the existing gap in
evidence-based psychological treatments for people with dementia. In this regard, it
can be seen as a fundamental step toward shifting some of the focus from pharmaco-
logic treatments to psychological ones. The positive effects of CST further amplified
the importance of looking beyond antidementia medication and it fueled the realization
that the two might actually provide the most optimal benefits to people with dementia
when combined. Findings regarding experiences of people with dementia were just as
encouraging; people have reported enjoyment and even increased confidence after
CST. Therefore, CST has managed to provide both a meaningful and stimulating
way for people with dementia to spend their time. The success of the original group
CST made it possible to go even further and develop extensions of group CST
ensuring that the intervention can be offered to people with different needs. In addi-
tion, the adaptation guidelines made it possible for CST to successfully be adapted
and offered in a variety of countries around the world.
Still, there is more to be explored in the field of CST because some questions remain
unanswered. The optimal dose for long-term CST is unknown and future research
could help to give an indication of what the most beneficial duration and frequency
of CST could be. Other work could focus on experimenting with iCST; for example,
enhancing methods of support and training could help to improve adherence. In terms
of exploring different platforms for CST, incorporating technology seems to be an
attractive option; the use of technology can benefit the cognitive functioning of older
people. A pilot study in Italy has investigated a tablet-based version of CST that can be
delivered at home.33 Results suggest the need for more research in this area.
For the future, we hope tomaintain this growth of CST and explore different avenues
for offering CST on both a national and international level. We aim to continue con-
necting stakeholders from around the world at our CST conferences and generate
ideas and discussions on what works and what can be done even better. This would
help to create an even better understanding of CST and encourage other researchers
and clinicians to explore the field of CST so that CST will continue to be available to
people with dementia who want and need it.
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